Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Vivi Li -- 3145 2022-10-13 01:31:36

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. RNA Vaccine. Encyclopedia. Available online: https://encyclopedia.pub/entry/29933 (accessed on 25 September 2026).
HandWiki. RNA Vaccine. Encyclopedia. Available at: https://encyclopedia.pub/entry/29933. Accessed September 25, 2026.
HandWiki. "RNA Vaccine" Encyclopedia, https://encyclopedia.pub/entry/29933 (accessed September 25, 2026).
HandWiki. (2022, October 18). RNA Vaccine. In Encyclopedia. https://encyclopedia.pub/entry/29933
HandWiki. "RNA Vaccine." Encyclopedia. Web. 18 October, 2022.
RNA Vaccine
Edit
The content is sourced from: https://handwiki.org/wiki/Medicine:RNA_vaccine

A ribonucleic acid (RNA) vaccine or messenger RNA (mRNA) vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine transfects molecules of synthetic RNA into immune cells, where the vaccine functions as mRNA, causing the cells to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell. These protein molecules stimulate an adaptive immune response which teaches the body to identify and destroy the corresponding pathogen or cancer cells. The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles which protect the RNA strands and help their absorption into the cells. Reactogenicity, the tendency of a vaccine to produce adverse reactions, is similar to that of conventional non-RNA vaccines. People susceptible to an autoimmune response may have an adverse reaction to RNA vaccines. The advantages of RNA vaccines over traditional protein vaccines are ease of design, speed and lower cost of production, and the induction of both cellular and humoral immunity. RNA vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the disadvantage of requiring ultracold storage before distribution; other mRNA vaccines, such as the Moderna, CureVac, and Walvax COVID-19 vaccines, do not require such ultracold storage temperatures. In RNA therapeutics, mRNA vaccines have attracted considerable interest as COVID-19 vaccines. In December 2020, Pfizer–BioNTech and Moderna obtained approval for their mRNA-based COVID-19 vaccines. On 2 December, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) became the first medicines regulator to approve an mRNA vaccine, authorizing the Pfizer–BioNTech vaccine for widespread use. On 11 December, the US Food and Drug Administration (FDA) issued an emergency use authorization for the Pfizer–BioNTech vaccine and a week later similarly approved the Moderna vaccine. The use of RNA in vaccines has occasioned substantial misinformation in social media, wrongly claiming that the introduction of RNA alters a person's DNA.

lipid nanoparticles ribonucleic acid ultracold

References

  1. "mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection". International Journal of Molecular Sciences 21 (18): 6582. September 2020. doi:10.3390/ijms21186582. PMID 32916818. "Initiation of cationic lipid-mediated mrna transfection; Concept proposal of mRNA-based drugs.".  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7554980
  2. "Cationic liposome-mediated RNA transfection". Proceedings of the National Academy of Sciences of the United States of America 86 (16): 6077–81. August 1989. doi:10.1073/pnas.86.16.6077. PMID 2762315. Bibcode: 1989PNAS...86.6077M.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=297778
  3. "Three decades of messenger RNA vaccine development". Nano Today 28: 100766. October 2019. doi:10.1016/j.nantod.2019.100766. https://biblio.ugent.be/publication/8628303. 
  4. "Direct gene transfer into mouse muscle in vivo". Science 247 (4949 Pt 1): 1465–8. March 1990. doi:10.1126/science.1690918. PMID 1690918. Bibcode: 1990Sci...247.1465W.  https://dx.doi.org/10.1126%2Fscience.1690918
  5. "After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases". Nature. May 31, 2021. https://www.nature.com/articles/s41591-021-01393-8?proof=t%29.. "When the broad range of vaccines against COVID-19 were being tested in clinical trials, only a few experts expected the unproven technology of mRNA to be the star. Within 10 months, mRNA vaccines were both the first to be approved and the most effective. Although these are the first mRNA vaccines to be approved, the story of mRNA vaccines starts more than 30 years ago, with many bumps in the road along the way. In 1990, the late physician-scientist Jon Wolff and his University of Wisconsin colleagues injected mRNA into mice, which caused cells in the mice to produce the encoded proteins. In many ways, that work served as the first step toward making a vaccine from mRNA, but there was a long way to go—and there still is, for many applications." 
  6. "mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection". International Journal of Molecular Sciences 21 (18): 6582. September 2020. doi:10.3390/ijms21186582. PMID 32916818. "Concept proposal of mRNA vaccines (1990)".  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7554980
  7. "Messenger RNA-based vaccines". Expert Opinion on Biological Therapy 4 (8): 1285–94. August 2004. doi:10.1517/14712598.4.8.1285. PMID 15268662.  https://dx.doi.org/10.1517%2F14712598.4.8.1285
  8. "Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA". European Journal of Immunology 23 (7): 1719–22. July 1993. doi:10.1002/eji.1830230749. PMID 8325342.  https://dx.doi.org/10.1002%2Feji.1830230749
  9. "A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs". Therapeutic Advances in Vaccines 2 (1): 10–31. January 2014. doi:10.1177/2051013613508729. PMID 24757523.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3991152
  10. "Characterization of a messenger RNA polynucleotide vaccine vector". Cancer Research 55 (7): 1397–400. April 1995. PMID 7882341. https://pubmed.ncbi.nlm.nih.gov/7882341/. 
  11. "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA" (in English). Immunity 23 (2): 165–75. August 2005. doi:10.1016/j.immuni.2005.06.008. PMID 16111635.  https://dx.doi.org/10.1016%2Fj.immuni.2005.06.008
  12. "BioNTech's founders: scientist couple in global spotlight" (in en). 2020-11-13. https://www.france24.com/en/live-news/20201113-biontech-s-founders-scientist-couple-in-global-spotlight. 
  13. "The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race". 10 November 2020. https://www.statnews.com/2020/11/10/the-story-of-mrna-how-a-once-dismissed-idea-became-a-leading-technology-in-the-covid-vaccine-race/. 
  14. "How a secretive Pentagon agency seeded the ground for a rapid coronavirus cure". The Washington Post. July 30, 2020. https://www.washingtonpost.com/national-security/how-a-secretive-pentagon-agency-seeded-the-ground-for-a-rapid-coronavirus-cure/2020/07/30/ad1853c4-c778-11ea-a9d3-74640f25b953_story.html. 
  15. "DARPA's gambles might have created the best hopes for stopping COVID-19". BioCentury. March 19, 2020. https://www.biocentury.com/article/304691/darpa-s-gambles-might-have-created-the-best-hopes-for-stopping-covid-19. 
  16. "DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics". 2 October 2013. https://www.prnewswire.com/news-releases/darpa-awards-moderna-therapeutics-a-grant-for-up-to-25-million-to-develop-messenger-rna-therapeutics-226115821.html. 
  17. "Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine". 10 January 2017. https://www.statnews.com/2017/01/10/moderna-trouble-mrna/. "struggling to get mRNA into cells without triggering nasty side effects" 
  18. "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". 13 September 2016. https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/. "because it’s exceedingly hard to get RNA into cells without triggering nasty side effects" 
  19. "COVID-19 and Your Health" (in en-us). 11 February 2020. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html. 
  20. "UK authorises Pfizer/BioNTech COVID-19 vaccine" (Press release). Department of Health and Social Care. 2 December 2020. https://www.gov.uk/government/news/uk-authorises-pfizer-biontech-covid-19-vaccine
  21. "UK approves Pfizer/BioNTech Covid vaccine for rollout next week". The Guardian. 2 December 2020. https://www.theguardian.com/society/2020/dec/02/pfizer-biontech-covid-vaccine-wins-licence-for-use-in-the-uk. 
  22. "Covid Pfizer vaccine approved for use next week in UK". BBC News. 2 December 2020. https://www.bbc.com/news/health-55145696. 
  23. Office of the Commissioner (18 December 2020). "Pfizer-BioNTech COVID-19 Vaccine" (in en). https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine. 
  24. "Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection". Advanced Drug Delivery Reviews 169: 168–89. December 2020. doi:10.1016/j.addr.2020.12.006. PMID 33316346.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7733686
  25. "Non-viral COVID-19 vaccine delivery systems". Advanced Drug Delivery Reviews 169: 137–51. December 2020. doi:10.1016/j.addr.2020.12.008. PMID 33340620.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7744276
  26. "SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates". NPJ Vaccines 6 (1): 28. February 2021. doi:10.1038/s41541-021-00292-w. PMID 33619260.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7900244
  27. "Recombinant vector vaccine evolution". PLOS Computational Biology 15 (7): e1006857. July 2019. doi:10.1371/journal.pcbi.1006857. PMID 31323032. Bibcode: 2019PLSCB..15E6857B.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6668849
  28. "Tools for translation: non-viral materials for therapeutic mRNA delivery". Nature Reviews Materials 2 (10): 17056. 12 September 2017. doi:10.1038/natrevmats.2017.56. Bibcode: 2017NatRM...217056H.  https://dx.doi.org/10.1038%2Fnatrevmats.2017.56
  29. "Developing mRNA-vaccine technologies". RNA Biology 9 (11): 1319–30. November 2012. doi:10.4161/rna.22269. PMID 23064118.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3597572
  30. "mRNA vaccines – a new era in vaccinology". Nature Reviews. Drug Discovery 17 (4): 261–79. April 2018. doi:10.1038/nrd.2017.243. PMID 29326426.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5906799
  31. "Review the safety of Covid-19 mRNA vaccines: a review". Patient Safety in Surgery 15 (1): 20. May 2021. doi:10.1186/s13037-021-00291-9. PMID 33933145.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=8087878
  32. "How do the new COVID-19 vaccines work?". Scope. Stanford Medicine. December 22, 2020. https://scopeblog.stanford.edu/2020/12/22/how-do-the-new-covid-19-vaccines-work/. 
  33. "mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection". International Journal of Molecular Sciences 21 (18): 6582. September 2020. doi:10.3390/ijms21186582. PMID 32916818.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7554980
  34. "mRNA Cancer Vaccines". Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres dans les Recherches Sur le Cancer. Recent Results in Cancer Research 209: 61–85. 2016. doi:10.1007/978-3-319-42934-2_5. ISBN 978-3-319-42932-8. PMID 28101688.  https://dx.doi.org/10.1007%2F978-3-319-42934-2_5
  35. "Seven vital questions about the RNA Covid-19 vaccines emerging from clinical trials". 19 November 2020. https://wellcome.org/news/seven-vital-questions-about-rna-covid-19-vaccines-pfizer-biontech-moderna. 
  36. "Moderna's groundbreaking coronavirus vaccine was designed in just 2 days". 26 November 2020. https://www.businessinsider.com/moderna-designed-coronavirus-vaccine-in-2-days-2020-11?r=US&IR=T. 
  37. "Introduction to RNA Vaccines". RNA Vaccines: Methods and Protocols. Methods in Molecular Biology. 1499. 2017. pp. 1–11. doi:10.1007/978-1-4939-6481-9_1. ISBN 978-1-4939-6479-6.  https://dx.doi.org/10.1007%2F978-1-4939-6481-9_1
  38. "COVID-19 vaccines poised for launch, but impact on pandemic unclear". Nature Biotechnology. November 2020. doi:10.1038/d41587-020-00022-y. PMID 33239758. https://www.nature.com/articles/d41587-020-00022-y. 
  39. "Vaccine rumours debunked: Microchips, 'altered DNA' and more". 15 November 2020. https://www.bbc.com/news/54893437. 
  40. "RNA Covid-19 vaccines will not change your DNA". 30 November 2020. https://fullfact.org/online/rna-vaccine-covid/. 
  41. "mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection". International Journal of Molecular Sciences 21 (18): 6582. September 2020. doi:10.3390/ijms21186582. PMID 32916818.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7554980
  42. "mRNA-based dendritic cell vaccines". Expert Review of Vaccines 14 (2): 161–76. February 2015. doi:10.1586/14760584.2014.957684. PMID 25196947.  https://dx.doi.org/10.1586%2F14760584.2014.957684
  43. "Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity". Cancer Research 70 (22): 9031–40. November 2010. doi:10.1158/0008-5472.can-10-0699. PMID 21045153.  https://dx.doi.org/10.1158%2F0008-5472.can-10-0699
  44. "Vaccine components" (in en). 22 September 2016. https://www.immune.org.nz/vaccines/vaccine-development/vaccine-components. 
  45. "Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent". Gene Therapy 14 (15): 1175–80. August 2007. doi:10.1038/sj.gt.3302964. PMID 17476302.  https://dx.doi.org/10.1038%2Fsj.gt.3302964
  46. "Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway". RNA Biology 8 (4): 627–36. July 2011. doi:10.4161/rna.8.4.15394. PMID 21654214.  https://dx.doi.org/10.4161%2Frna.8.4.15394
  47. Template:Primary-source inline"Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients". Journal of Immunotherapy 32 (5): 498–507. June 2009. doi:10.1097/CJI.0b013e3181a00068. PMID 19609242.  https://dx.doi.org/10.1097%2FCJI.0b013e3181a00068
  48. "mRNA vaccine: a potential therapeutic strategy". Molecular Cancer 20 (1): 33. February 2021. doi:10.1186/s12943-021-01311-z. PMID 33593376.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7884263
  49. "How nanotechnology helps mRNA Covid-19 vaccines work". 1 December 2020. https://www.statnews.com/2020/12/01/how-nanotechnology-helps-mrna-covid19-vaccines-work/. 
  50. "mRNA vaccine delivery using lipid nanoparticles". Therapeutic Delivery 7 (5): 319–34. May 2016. doi:10.4155/tde-2016-0006. PMID 27075952.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5439223
  51. "Without these lipid shells, there would be no mRNA vaccines for COVID-19". Chemical & Engineering News (American Chemical Society). March 6, 2021. https://cen.acs.org/pharmaceuticals/drug-delivery/Without-lipid-shells-mRNA-vaccines/99/i8. 
  52. "A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation". Nano Letters 18 (3): 2148–57. March 2018. doi:10.1021/acs.nanolett.8b00432. PMID 29489381. Bibcode: 2018NanoL..18.2148P.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6054134
  53. "Opinion: A straightforward explanation why more COVID-19 vaccines can't be produced with help from 'dozens' of companies". MarketWatch. February 3, 2021. https://www.marketwatch.com/story/lets-stick-to-facts-about-covid-19-vaccines-there-arent-dozens-of-drug-companies-who-can-step-in-to-produce-more-11612363386. 
  54. "Why manufacturing Covid vaccines at scale is hard". Chemistry World (Royal Society of Chemistry). 23 March 2021. https://www.chemistryworld.com/news/why-manufacturing-covid-vaccines-at-scale-is-hard/4013429.article#/. 
  55. "Manufacturing moonshot: How Pfizer makes its millions of Covid-19 vaccine doses". CNN. April 2, 2021. https://www.cnn.com/2021/03/31/health/pfizer-vaccine-manufacturing/index.html. 
  56. "Race to the Vaccine: A COVID-19 vaccine life cycle: from DNA to doses". USA Today (Gannett). 7 February 2021. https://www.usatoday.com/in-depth/news/health/2021/02/07/how-covid-vaccine-made-step-step-journey-pfizer-dose/4371693001/. 
  57. "mRNA Covid-19 Vaccines Are Fast to Make, but Hard to Scale". The Wall Street Journal. March 3, 2021. https://www.wsj.com/articles/mrna-covid-19-vaccines-are-fast-to-make-but-hard-to-scale-11614776401. 
  58. "Why grandparents can't find vaccines: Scarcity of niche biotech ingredients". The Washington Post. February 18, 2021. https://www.washingtonpost.com/business/2021/02/18/vaccine-fat-lipids-supply/. 
  59. "RNA Viruses as Tools in Gene Therapy and Vaccine Development". Genes 10 (3): 189. March 2019. doi:10.3390/genes10030189. PMID 30832256.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6471356
  60. "Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model". Human Gene Therapy 26 (2): 82–93. February 2015. doi:10.1089/hum.2014.100. PMID 25419577.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4326030
  61. "Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses". Virology 278 (1): 55–59. December 2000. doi:10.1006/viro.2000.0635. PMID 11112481.  https://dx.doi.org/10.1006%2Fviro.2000.0635
  62. "Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections". The Journal of Infectious Diseases 204 (Suppl 3): S1075–81. November 2011. doi:10.1093/infdis/jir349. PMID 21987744.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3218670
  63. PHG Foundation (2019). "RNA vaccines: an introduction". https://www.phgfoundation.org/briefing/rna-vaccines. 
  64. "Public needs to prep for vaccine side effects". Science 370 (6520): 1022. November 2020. doi:10.1126/science.370.6520.1022. PMID 33243869.  https://dx.doi.org/10.1126%2Fscience.370.6520.1022
  65. "Experts Tell F.D.A. It Should Gather More Safety Data on Covid-19 Vaccines". New York Times. 22 October 2020. https://www.nytimes.com/2020/10/22/health/covid-vaccine-fda-advisory-committee.html. 
  66. "Pfizer boss warns on risk of fast-tracking vaccines". Financial Times. 30 September 2020. https://www.ft.com/content/1a91c897-66d5-4bd5-ae9b-0b3be185dac8. 
  67. "Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling". Pfizer. https://www.cvdvaccine-us.com/product-storage-and-dry-ice. 
  68. "Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?". https://www.npr.org/sections/health-shots/2020/11/17/935563377/why-does-pfizers-covid-19-vaccine-need-to-be-kept-colder-than-antarctica. 
  69. "Fact Sheet for Healthcare Providers Administering Vaccine" (PDF). ModernaTX, Inc.. https://www.fda.gov/media/144637/download. 
  70. "Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures" (in en). https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-longer-shelf-life-its-covid-19-vaccine. 
  71. "From science to syringe: COVID-19 vaccines are miracles of science and supply chains". CTV News (Bell Media). February 27, 2021. https://www.ctvnews.ca/health/coronavirus/from-science-to-syringe-covid-19-vaccines-are-miracles-of-science-and-supply-chains-1.5327003. 
  72. "Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA". Immunity 23 (2): 165–75. August 2005. doi:10.1016/j.immuni.2005.06.008. PMID 16111635.  https://dx.doi.org/10.1016%2Fj.immuni.2005.06.008
  73. "Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA". Nucleic Acids Research 39 (21): e142. November 2011. doi:10.1093/nar/gkr695. PMID 21890902.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3241667
  74. "Nucleoside Modified mRNA Vaccines for Infectious Diseases". RNA Vaccines. Methods in Molecular Biology. 1499. Springer New York. 17 December 2016. pp. 109–21. doi:10.1007/978-1-4939-6481-9_6. ISBN 978-1-4939-6479-6.  https://dx.doi.org/10.1007%2F978-1-4939-6481-9_6
  75. "Developing mRNA-vaccine technologies". RNA Biology 9 (11): 1319–30. November 2012. doi:10.4161/rna.22269. PMID 23064118.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3597572
  76. "Enhancing immune responses using suicidal DNA vaccines". Nature Biotechnology 16 (6): 562–65. June 1998. doi:10.1038/nbt0698-562. PMID 9624688.  https://dx.doi.org/10.1038%2Fnbt0698-562
  77. "Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses". Molecular Therapy 26 (2): 446–55. February 2018. doi:10.1016/j.ymthe.2017.11.017. PMID 29275847.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5835025
  78. "Vaccine rumours debunked: Microchips, 'altered DNA' and more". BBC. 2 December 2020. https://www.bbc.co.uk/news/54893437. 
  79. Skalka AM (2014). "Retroviral DNA Transposition: Themes and Variations". Microbiology Spectrum 2 (5): 1101–23. doi:10.1128/microbiolspec.MDNA3-0005-2014. ISBN 9781555819200. PMID 25844274.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4383315
  80. "The Promise of mRNA Vaccines". The Scientist. 25 November 2020. https://www.the-scientist.com/news-opinion/the-promise-of-mrna-vaccines-68202. Retrieved 27 November 2020. 
  81. "Could mRNA COVID-19 vaccines be dangerous in the long-term?". The Jerusalem Post. 17 November 2020. https://www.jpost.com/health-science/could-an-mrna-vaccine-be-dangerous-in-the-long-term-649253. 
  82. "Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines". Expert Opin Drug Deliv 11 (6): 885–99. June 2014. doi:10.1517/17425247.2014.901308. PMID 24665982.  https://dx.doi.org/10.1517%2F17425247.2014.901308
  83. "Nonviral delivery of self-amplifying RNA vaccines". Proc Natl Acad Sci U S A 109 (36): 14604–09. September 2012. doi:10.1073/pnas.1209367109. PMID 22908294. Bibcode: 2012PNAS..10914604G.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3437863
  84. "Self-replicating Semliki Forest virus RNA as recombinant vaccine". Vaccine 12 (16): 1510–14. December 1994. doi:10.1016/0264-410x(94)90074-4. PMID 7879415.  https://dx.doi.org/10.1016%2F0264-410x%2894%2990074-4
  85. "Self-amplifying RNA vaccines for infectious diseases". Gene Therapy 28 (3–4): 117–129. April 2021. doi:10.1038/s41434-020-00204-y. PMID 33093657.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7580817
  86. "saRNA Biology | About Self-Amplifying RNA Genome & How It Works". https://www.chimeron.com/sarna-biology/. 
  87. "A Malaria Vaccine Candidate". 2021-03-01. https://blogs.sciencemag.org/pipeline/archives/2021/03/01/a-malaria-vaccine-candidate. 
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Cell Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
HandWiki
View Times: 2.2K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 18 Oct 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback